2don MSN
Seattle startup Accipiter Bio emerges with $12.7M and big pharma deals for AI-designed proteins
A Seattle biotech startup born from a Nobel laureate's lab has landed $12.7 million and partnerships with pharmaceutical ...
Which Is a Better Investment, Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. Stock?
Learn more about whether Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.5, a high ...
BioMarin Pharmaceutical (NASDAQ: BMRN) reported its third-quarter earnings after market close Monday, and they were good ...
AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...
Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital transformation, streamlined operations and strategic partnerships to ...
TipRanks on MSN
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Announces Extraordinary General Meeting for Strategic Amendments
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ) has provided an announcement. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., ...
Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.
The Chosun Ilbo on MSN
Pharmaceutical, Biotech Industries Avoid 100% Tariffs
Earlier, President Trump stated that companies without factories in the U.S. would face 100% tariffs on their pharmaceuticals ...
Learn more about whether BioMarin Pharmaceutical Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback